House Subpoenas FDA Staffers In Ketek Investigation
This article was originally published in The Pink Sheet Daily
Executive Summary
Von Eschenbach’s congressional briefing documents also subpoenaed as panel delves into when FDA and Sanofi-Aventis became aware of flawed safety study.